Clinical Coagulation, Malmö
1 – 10 of 488
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII
- Impact of Exercise on Hemophilia
- The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
- Defining extended half-life rFVIII-A critical review of the evidence
- Replacement therapy during surgery in von Willebrand disease needs personalization
- Evaluation of global coagulation tests and their implications in haemophilia
- Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner
- Current evidence of oral anticoagulant reversal : A systematic review
- Factor V Leiden paradox in a middle-aged Swedish population : A prospective study
- Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients